-
DEPARTMENT OF HEALTH
NOTICE OF EMERGENCY RULEMAKING
The Acting Director of the Department of Health, pursuant to the authority set forth in § 201(a) of the District of Columbia Uniform Controlled Substances Act of 1981, effective August 5, 1981 (D.C. Law 4-29; D.C. Official Code § 48-902.01(a) (2012 Repl.) and Mayor's Order 98-49, dated April 15, 1998, hereby gives notice of the adoption, on an emergency basis, of the following amendments to Section 1201.1 of Chapter 12 (Controlled Substances Act Rules) of Subtitle B (Public Health & Medicine), Title 22 (Health), of the District of Columbia Municipal Regulations (DCMR).
The emergency rules would amend the list of Schedule I drugs to include cannabimimetic agents. Emergency rulemakings are necessary for the immediate preservation of the public peace, health, safety, welfare, or morals, pursuant to 1 DCMR § 311.4(e). Emergency action is necessary because the cannabimimetic drugs have no legitimate medical use, are readily available, and pose an immediate risk to public health and safety because of their harmful effects when abused. Those effects of abuse include vomiting, anxiety, agitation, irritability, seizures, hallucinations, tachycardia, elevated blood pressure, and loss of consciousness.
The emergency rulemaking was adopted on November 4, 2013, and will remain in effect for one hundred twenty (120) days or until March 4, 2014, unless superseded by publication of another rulemaking notice in the D.C. Register.
Section 1201.1 of Subtitle B (Public Health & Medicine), Title 22 (Health), of the DCMR is amended by adding a new paragraph (f) to read as follows:
(f) Cannabimimetic agents: Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of any of the following substances or its salts, isomers, salts of isomers, analogs or derivatives, whenever the existence of such salts, isomers, salts of isomers, analogs or derivatives is possible within the specific chemical designation:
(1) 1-pentyl-1 H -indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (other names: UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl) indole);
(2) [1-(5-fluoro-pentyl)-1 H -indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone (other names: 5-fluoro-UR-144, 5-F-UR-144, XLR11, 1-(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl) indole); and
(3) N -(1-adamantyl)-1-pentyl-1 H -indazole-3-carboxamide (other names: APINACA, AKB48).
